n-(2-hydroxypropyl)methacrylamide has been researched along with Peritoneal Carcinomatosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Briggs, SS; Chandler, L; Fisher, KD; Green, NK; Hale, S; Mautner, V; Morrison, J; Seymour, LW; Stevenson, M; Subr, V; Ulbrich, K | 1 |
1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Peritoneal Carcinomatosis
Article | Year |
---|---|
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
Topics: Acrylamides; Adenoviridae; Animals; Antibodies, Monoclonal; Female; Genetic Therapy; Genetic Vectors; Humans; Mice; Ovarian Neoplasms; Peritoneal Neoplasms; Polymers; Receptors, Fibroblast Growth Factor; Transduction, Genetic; Transgenes; Tumor Cells, Cultured | 2008 |